He Jiankui stands by a controversial research approach that landed him in prison as he aims to tackle Alzheimer’s disease.

Science is discovery and discovery evolve. Few discoveries have elicited as much excitement in the scientific world in recent times ...

Early in the beginning of the COVID-19 pandemic, scientists predicted the SARS-CoV-2 virus would mutate slowly. They were wrong. Hundreds of thousands of viral mutations and multiple seasonal waves ...

A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...

No HIV infections were seen in any of the study arms ... The remaining three of them had mutations that made them resistant ...

Emory University's pioneering work with a class of small molecules known as JAK (janus kinase) inhibitors continues to show how HIV might be cured ...

A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly mutating ...

A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells ...

Successful high-affinity B cells can proliferate under special conditions that reduce the risk of mutation. Capturing this ...

Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...

Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...